EUVIMEDEUVIMED entdecken
Open Access

Capillary flow-driven immunoassay platform for COVID-19 antigen diagnostics

Jeremy S Link, Cody S Carrell, Ilhoon Jang, Elijah J O Barstis, Zachary D Call, Rae A Bellows, John J O'Donnell-Sloan, James S Terry, Loran B R Anderson, Yosita Panraksa, Brian J Geiss, David S Dandy und 1 weitere

Analytica Chimica Acta · 2023

DOI: 10.1016/j.aca.2023.341634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Jeremy S Link und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Colorado State University, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last few years, the SARS-CoV-2 pandemic has made the need for rapid, affordable diagnostics more compelling than ever. While traditional laboratory diagnostics like PCR and well-plate ELISA are sensitive and specific, they can be costly and take hours to complete. Diagnostic tests that can be used at the point-of-care or at home, like lateral flow assays (LFAs) are a simple, rapid alternative, but many commercially available LFAs have been criticized for their lack of sensitivity compared to laboratory methods like well-plate ELISAs. The Capillary-Driven Immunoassay (CaDI) device described in this work uses microfluidic channels and capillary action to passively automate the steps of a traditional well-plate ELISA for visual read out. This work builds on prior capillary-flow devices by further simplifying operation and use of colorimetric detection. Upon adding sample, an enzyme-conjugated secondary antibody, wash steps, and substrate are sequentially delivered to test and control lines on a nitrocellulose strip generating a colorimetric response. The end user can visually detect SARS-CoV-2 antigen in 15-20 min by naked eye, or results can be quantified using a smartphone and software such as ImageJ. An analytical detection limit of 83 PFU/mL for SARS-CoV-2 was determined for virus in buffer, and 222 PFU/mL for virus spiked into nasal swabs using image analysis, similar to the LODs determined by traditional well-plate ELISA. Additionally, a visual detection limit of 100 PFU/mL was determined in contrived nasal swab samples by polling 20 untrained end-users. While the CaDI device was used for detecting clinically relevant levels of SARS-CoV-2 in this study, the CaDI device can be easily adapted to other immunoassay applications by changing the reagents and antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2ImmunoassayEnzyme-Linked Immunosorbent AssayAntibodiesCOVID-19 Testing

Stichwörter der Autor:innen

COVID-19Capillary-driven microfluidicsDiagnostic testingImmunoassaysPoint-of-careSARS-CoV-2

Substanzen

Antibodies

Autor:innen und Institutionen

  • Department of Chemistry, Colorado State University, USA.
  • Department of Chemistry, Colorado State University, USA; Institute of Nano Science and Technology, Hanyang University, South Korea.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, USA.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, USA; Myobacteria Research Laboratories, Colorado State University, USA.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, USA; School of Biomedical Engineering, Colorado State University, USA.
  • Department of Chemical and Biological Engineering, Colorado State University, USA; School of Biomedical Engineering, Colorado State University, USA.

Förderung

  • NIAID NIH HHS
  • NIBIB NIH HHS
  • NHLBI NIH HHS
  • National Science Foundation
  • National Institutes of Health

Zitieren

APA

Link, J. S., Carrell, C. S., Jang, I., Barstis, E. J. O., Call, Z. D., Bellows, R. A., O'Donnell-Sloan, J. J., Terry, J. S., Anderson, L. B. R., Panraksa, Y., Geiss, B. J., Dandy, D. S., & Henry, C. S. (2023). Capillary flow-driven immunoassay platform for COVID-19 antigen diagnostics. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341634

Vancouver

Link JS, Carrell CS, Jang I, Barstis EJO, Call ZD, Bellows RA, et al. Capillary flow-driven immunoassay platform for COVID-19 antigen diagnostics. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341634

BibTeX
@article{Link2023,
  author = {Link, Jeremy S and Carrell, Cody S and Jang, Ilhoon and Barstis, Elijah J O and Call, Zachary D and Bellows, Rae A and O'Donnell-Sloan, John J and Terry, James S and Anderson, Loran B R and Panraksa, Yosita and Geiss, Brian J and Dandy, David S and Henry, Charles S},
  title = {Capillary flow-driven immunoassay platform for COVID-19 antigen diagnostics},
  journal = {Analytica Chimica Acta},
  year = {2023},
  doi = {10.1016/j.aca.2023.341634}
}
Kostenlos starten →